D-0301-2026 Class II Ongoing

Recalled by Unichem Pharmaceuticals USA Inc. — East Brunswick, NJ

FDA drug recall D-0301-2026 was initiated by Unichem Pharmaceuticals USA Inc. on Jan 21, 2026 and is designated Class II. Reason for recall: cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits. The recall status is ongoing.

Recall details

Product Type
Drugs
Report Date
Feb 11, 2026
Initiation Date
Jan 21, 2026
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIS LTD., Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India, Manufactured for: UNICHEM PHARMACEUTICALS (USA), INC., East Brunswick, NJ 08816, NDC 29300-187-01

Reason for recall

cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.

Distribution pattern

US Nationwide and PR.

Code information

Lot # GBHL24005A, Exp Date: 09/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0301-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0301-2026. Report a data issue: hello@regdatalab.com.